News

Hosted on MSN5mon
FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment
The Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow.
NBC 10 Philadelphia5mon
FDA approves Johnson & Johnson’s nasal spray for depression – NBC10 Philadelphia
FDA approves Johnson & Johnson's nasal spray for depression as standalone treatment By Annika Kim Constantino,CNBC • Published January 21, 2025 • Updated on January 21, 2025 at 11:04 am BOOKMARKER ...
NBC Washington5mon
FDA approves Johnson & Johnson’s nasal spray for depression – NBC4 Washington
FDA approves Johnson & Johnson's nasal spray for depression as standalone treatment By Annika Kim Constantino,CNBC • Published January 21, 2025 • Updated on January 21, 2025 at 11:04 am BOOKMARKER ...
NBC Connecticut5mon
FDA approves Johnson & Johnson's nasal spray for depression as standalone treatment - NBC Connecticut
The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug ...
NBC DFW5mon
FDA approves Johnson & Johnson’s nasal spray for depression – NBC 5 Dallas-Fort Worth
The Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow. The ...
UPI5mon
FDA approves Spravato, first monotherapy nasal spray to treat depression - UPI
Johnson & Johnson’s Spravato nasal spray has been approved to treat a major depressive disorder in adults who have had an inadequate response to at least two oral antidepressants, the FDA ...
NBC Chicago5mon
FDA approves Johnson & Johnson’s nasal spray for depression – NBC Chicago
FDA approves Johnson & Johnson's nasal spray for depression as standalone treatment By Annika Kim Constantino,CNBC • Published January 21, 2025 • Updated on January 21, 2025 at 10:04 am BOOKMARKER ...
NBC 7 San Diego5mon
FDA approves Johnson & Johnson's nasal spray for depression as standalone treatment - NBC 7 San Diego
The Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow.
NBC 6 South Florida5mon
FDA approves Johnson & Johnson’s nasal spray for depression – NBC 6 South Florida
The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug ...
AOL5mon
FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment - AOL
Major depressive disorder affects an estimated 8.3% of the adult population. And now there’s a new option for treatment: Spravato, a nasal spray that’s been shown to give rapid relief to ...
NBC Los Angeles5mon
FDA approves Johnson & Johnson's nasal spray for depression as standalone treatment - NBC Los Angeles
The Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow. The ...